Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Alan M. Miller is active.

Publication


Featured researches published by Alan M. Miller.


Journal of Clinical Investigation | 1981

Immunological and functional differences between human type I and II colony-stimulating factors.

Ming-Chi Wu; Alan M. Miller; Adel A. Yunis

Two distinct types of colony-stimulating factor (CSF) have recently been described in human tissues and cultured cell lines. Antisera to purified type I and II CSF were prepared in rabbits. Anti-CSF I antibody inhibits CSF I, but has no effect on CSF II. It cross-inhibits CSF I from several other human sources, but does not inhibit CSF from mouse lung or mouse L cells. Anti-CSF II antibody inhibits the activity of CSF II, but has no effect on CSF I. A radioimmunoassay for CSF I has been established. Competitive binding assay further demonstrated the immunological differences between CSF I and II. When CSF II is used to stimulate human marrow cells fractionated by sedimentation velocity, two populations of CFU-C are separated, one sedimenting at 8 mm/h and forming colonies by day 7, and a second sedimenting at 6.8 mm/h and forming colonies by day 13. In contrast, CSF I does nt stimulate colony growth by day 7 but does do so by day 13 in cells sedimenting between 7.2-8.5 mm/h. These results indicate that CSF I and II are distinct in their biochemical, immunological, and functional properties.


Journal of Laboratory and Clinical Medicine | 1980

Nitroso-chloramphenicol: Possible mediator in chloramphenicol-induced aplastic anemia

Adel A. Yunis; Alan M. Miller; Ziad Salem; Corbett; Grace K. Arimura


Clinical Toxicology | 1980

Chloramphenicol toxicity: pathogenetic mechanisms and the role of the p-NO2 in aplastic anemia.

Adel A. Yunis; Alan M. Miller; Ziad Salem; Grace K. Arimura


Journal of Laboratory and Clinical Medicine | 1978

Heterogeneity of human colony-forming cells (CFU-C): differences in size, rate of colony formation, and responsiveness to colony-stimulating factor

Alan M. Miller; M. A. Gross; Adel A. Yunis


Journal of Cellular Physiology | 1982

Induced release and metabolism of arachidonic acid from myeloid cells by purified colony-stimulating factor.

Vincent A. Ziboh; Alan M. Miller; Ming-Chi Wu; Adel A. Yunis; Joaquin J. Jimenez; Glen Wong


Journal of Laboratory and Clinical Medicine | 1978

Modulation of granulopoiesis: opposing roles of prostaglandins F and E.

Alan M. Miller; Thomas Russell; M. A. Gross; Adel A. Yunis


American Journal of Hematology | 1980

Mechanisms of levamisole-induced granulocytopenia in breast cancer patients

Charles L. Vogel; Michael A. Silverman; Peter W. Mansell; Alan M. Miller; John S. Thompson; John M. Herbick; Dennis E. Brunskill; Darlene C. Padgett; E. Churchill McKinney; Everett V. Sugarbaker


International Journal of Cancer | 1984

Lymphoreticular cells isolated by centrifugal elutriation from a mammary adenocarcinoma. I. Characterization of an in situ lymphocyte suppressor population by surface markers and functional reactivity.

Scott C. Buessow; Ronald D. Paul; Alan M. Miller; Diana M. Lopez


Blood cells | 1980

Antibody to purified human colony-stimulating factor: use in the identification and isolation of granulocyte macrophage progenitor cells.

Yunis Aa; Ming-Chi Wu; Alan M. Miller; Ingram M; Files N


Experimental Hematology | 1978

In vitro evidence for genetically determined variations in marrow erythroid cell sensitivity to chloramphenicol.

Alan M. Miller; Grace K. Arimura; M.A. Gross; Yunis Aa

Collaboration


Dive into the Alan M. Miller's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge